Spanish
Every May 27th, the Type II Collagenopathy Awareness Day is commemorated, a date intended to inform, educate, and raise awareness about a group of rare genetic diseases that affect thousands of people worldwide and that, in many cases, remain underdiagnosed for years.
Type II collagenopathies are hereditary disorders caused by alterations in the COL2A1 gene, responsible for producing type II collagen, a fundamental protein for the formation and maintenance of cartilage, bones, eyes, and other structures of the body. When this gene has mutations, various conditions can occur that affect skeletal development and cause complications of varying severity.
Among the diseases that are part of this group are Stickler syndrome, congenital spondyloepiphyseal dysplasia, Kniest dysplasia, and other rare conditions that can manifest from birth or during infancy. Their symptoms include short stature, bone deformities, joint problems, visual impairments, hearing loss, and difficulties in physical development.
The Type II Collagenopathy Awareness Day seeks to increase public knowledge about these diseases, promote early diagnosis, and encourage access to specialized medical services. Because many of these pathologies are little known, patients often face long processes to obtain an accurate diagnosis, which can delay treatments and affect their quality of life.
We recommend reading:
Specialists point out that early detection allows the implementation of follow-up strategies and clinical management that help prevent complications and improve the well-being of patients. Therefore, the education of health professionals, families, and communities is essential to identify warning signs and facilitate adequate care.
The day also recognizes the role of patient and family organizations, which work to provide emotional support, guidance, and accompaniment to those living with these conditions. Likewise, it promotes scientific research aimed at better understanding the genetic mechanisms of these diseases and developing new therapeutic alternatives.
Although type II collagenopathies are considered rare diseases, their impact on the lives of patients and their families is significant. For this reason, every May 27th becomes an opportunity to promote inclusion, empathy, and commitment to the health of those affected, as well as to reinforce the importance of research and equitable access to specialized medical care.
The commemoration recalls that visibility and information are essential tools for improving the diagnosis, treatment, and quality of life of those living with these complex genetic diseases.
